# Maxcyte, Inc.: Form 8-K, filed Dec 11, 2023

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2023-12-11
- Accepted by EDGAR: Dec 11, 2023, 16:30 ET
- Period: 2023-12-10
- Accession: 0001558370-23-019718
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000155837023019718/mxct-20231210x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000155837023019718/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000155837023019718/mxct-20231210x8k.htm

Filed Dec 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-019718. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.